Ó³»­´«Ã½

Lloyd Bod
Associate Member
Ó³»­´«Ã½

Principal investigator
Krantz Family Center for Cancer Research
Massachusetts General Hospital

Assistant Professor of Medicine
Harvard Medical School

The immune system's immense variety of cells and tissues all play specific roles in defending us from pathogens, watching for tumors, keeping the system from inadvertently turning against us, and more. Its T cells in particular are famous for their ability to attack tumors, leading to immunotherapies that have revolutionized cancer treatment. But by focusing on T cells, are we missing other opportunities to combat cancer? Immunologist Lloyd Bod will take us on a tour of the immune system, and discuss new insights that may help scientists and doctors leverage its cancer-fighting capabilities more effectively.

Lloyd Bod is an associate member of Ó³»­´«Ã½, a principal investigator in the Krantz Family Center for Cancer Research at Massachusetts General Hospital, and an assistant professor of medicine at Harvard Medical School. Studies of cancer immunotherapy have largely focused on T cells, but the Bod lab seeks to understand whether the immune system's antibody-producing B cells can also be leveraged for cancer treatment. By exploring the landscape of B cell states in tumors, and the mechanisms by which B cells control tumor growth, they hope to learn how to harness anti-tumor immune responses for treatment more effectively.

The Ó³»­´«Ã½ Discovery Series brings researchers to the stage to discuss and answer questions about some of the most pressing topics in science and medicine today. Held in-person and virtually at the Ó³»­´«Ã½ of MIT and Harvard, these free public events explore the genetic and biological roots of human health and disease, the mechanisms that govern how our cells and bodies function, new technologies that are changing what's possible in science, and the progress being made to translate these findings into treatments for common and rare diseases.

Learn more about the Ó³»­´«Ã½ Discovery Series.